Tag Archives: Announces

Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »

DSET 2021 Announces Tech Sponsor

DSET are excited to announce that Bohemia Interactive Simulations (BISim) will be the official Tech Sponsors for the 2021 hybrid event in March 22nd-24th 2021. As key players in the military training and simulation sector, we are honoured to welcome them as our Tech Sponsors and key exhibitors. BISim provides high-fidelity, cost effective training with… Read More »